Pharmaceuticals, Biotechnology and Life Sciences
BOSTON–(BUSINESS WIRE)–Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointment of Jeffrey Ecsedy, Ph.D.,…
$33.1M in Rubraca® (rucaparib) global sales for the first quarter of 2018 Updated data on 52 patients with BRCA-mutant mCRPC…
Positive Results Seen for Both Pain and Inflammation AUSTIN, Texas–(BUSINESS WIRE)–Mati Therapeutics Inc. (“Mati”) announced that it has completed a…
Promotion Reflects Vollmer’s Expanding Leadership Role with Company Since its 2014 Founding McKINNEY, Texas–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/soleohealthnamesCraigVollmerchiefcommericalofficer?src=hash" target="_blank"gt;#soleohealthnamesCraigVollmerchiefcommericalofficerlt;/agt;–Soleo Health, an innovative…
Experienced attorney to lead high-value intellectual property procurement and protection BERKELEY, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biochemicals?src=hash" target="_blank"gt;#biochemicalslt;/agt;–Lygos, Inc., a full-stack producer of…
DALLAS–(BUSINESS WIRE)–Peloton Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing first-in-class oral medicines for cancer and other serious conditions, announced that…
AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, an integrated research organization (IRO), announced today $20 million in Series C funding led by…
– Announces USAN selection of omidubicel as nonproprietary name for company’s investigational NAM-expanded hematopoietic stem cells (formerly known as NiCord®)…
Q3’19 revenue of $617.5 million decreased 2% as-reported, but increased 2% in constant currency, from Q3’18, while Q3’19 YTD revenue…
Patients across all age subgroups treated with ozanimod lost less cortical grey matter volume than did those treated with interferon…